Chemours (NYSE:CC) is preparing to appoint the chief executive of Vision One Management Partners to its board in an effort to ...

Chemours Co. plans to add the chief executive officer of Vision One Management Partners to its board as it seeks to avoid a ...

Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with ...

Opteon™ 2P50, Chemours’ developmental dielectric thermal management fluid, has an ultra-low global warming potential of 10 ...

Company announced the launch of a full-scale product trial with NTT Data and a regional engineering firm, Hibiya Engineering, ...

Chemours is expanding sampling eligibility to additional homes inside and neighboring southeastern North Carolina at the ...

The N.C. Department of Environmental Quality is continuing Chemours’ search for groundwater contamination beyond the Lower ...

North Carolina ordered Chemours to expand PFAS well testing, adding 150,000 homes in six counties, including Harnett and Hoke ...

Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $19.00.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Maryland has filed suit against W.L. Gore & Associates (Gore), a downstream user of PFAS-containing materials, alleging that ...

Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Chemours in a research note issued to investors on ...